The Fund seeks to achieve strong capital growth with a high degree of reliability over the long term. The Fund invests primarily in equities of companies outside of Canada and the United States.
Is this fund right for you?
- You want your money to grow over a longer term.
- You want to invest in companies outside of Canada and the U.S.
- You're comfortable with a medium level of risk.
Risk Rating
How is the fund invested?
(as of May 31, 2025)
Asset allocation (%)
|
Name |
Percent |
|
International Equity |
98.8 |
|
Cash and Equivalents |
1.2 |
Geographic allocation (%)
|
Name |
Percent |
|
Ireland |
18.4 |
|
Switzerland |
10.8 |
|
France |
10.7 |
|
United Kingdom |
9.7 |
|
Japan |
7.4 |
|
Denmark |
6.9 |
|
Germany |
5.8 |
|
Thailand |
5.6 |
|
Korea, Republic Of |
4.2 |
|
Other |
20.5 |
Sector allocation (%)
|
Name |
Percent |
|
Healthcare |
25.5 |
|
Financial Services |
16.7 |
|
Industrial Goods |
14.9 |
|
Consumer Goods |
14.9 |
|
Technology |
10.0 |
|
Energy |
5.8 |
|
Industrial Services |
3.8 |
|
Real Estate |
3.5 |
|
Telecommunications |
2.9 |
|
Other |
2.0 |
Growth of $10,000
(since inception)
Data not available based on date of inception
Fund details
(as of May 31, 2025)
Top holdings |
% |
Deutsche Boerse AG Cl N |
4.5 |
Bank of Ireland Group PLC |
4.2 |
Samsung Electronics Co Ltd |
4.2 |
Demant A/S |
3.9 |
Legrand SA |
3.8 |
Ryanair Holdings PLC - ADR |
3.8 |
Thai Beverage PCL |
3.7 |
GSK plc |
3.6 |
Dcc PLC |
3.6 |
Roche Holding AG - Partcptn |
3.6 |
Total allocation in top holdings |
38.9 |
Portfolio characteristics |
|
Standard deviation |
11.3% |
Dividend yield |
2.8% |
Average market cap (million) |
$146,965.6 |
Understanding returns
Annual compound returns (%)
1 MO |
3 MO |
YTD |
1 YR |
{{snapShot.Return1Mth|customNumber:1}} | {{snapShot.Return3Mth|customNumber:1}} | {{snapShot.ReturnYTD|customNumber:1}} | {{snapShot.Return1Yr|customNumber:1}} |
3 YR |
5 YR |
10 YR |
INCEPTION |
{{snapShot.Return3Yr|customNumber:1}} | {{snapShot.Return5Yr|customNumber:1}} | {{snapShot.Return10Yr|customNumber:1}} | {{snapShot.ReturnInception|customNumber:1}} |
Calendar year returns (%)
2024 |
2023 |
2022 |
2021 |
{{snapShot.Return1YrCalendar|customNumber:1}} | {{snapShot.Return2YrCalendar|customNumber:1}} | {{snapShot.Return3YrCalendar|customNumber:1}} | {{snapShot.Return4YrCalendar|customNumber:1}} |
2020 |
2019 |
2018 |
2017 |
{{snapShot.Return5YrCalendar|customNumber:1}} | {{snapShot.Return6YrCalendar|customNumber:1}} | {{snapShot.Return7YrCalendar|customNumber:1}} | {{snapShot.Return8YrCalendar|customNumber:1}} |
Range of returns over five years
(November 1, 2018 - July 31, 2025)
Best return |
Best period end date |
Worst return |
Worst period end date |
9.6% |
March 2025 |
0.9% |
Oct. 2023 |
Average return |
% of periods with positive returns |
Number of positive periods |
Number of negative periods |
4.9% |
100.0% |
22 |
0 |
Q2 2025 Fund Commentary
Market commentary
EAFE equities rose during the second quarter of 2025. The threat of economic disruption because of tariff conflicts declined as investors regained confidence in the strength of the U.S. consumer. In Europe, a new German Chancellor was appointed, with a mandate to increase fiscal stimulus. China continued to combat slow growth and deflationary dynamics in its local economy.
Performance
The Fund’s relative exposure to Ryanair Holdings PLC, Bank Leumi Le Israel BM and Taiwan Semiconductor Manufacturing Co. Ltd. had a positive impact on performance. Relative exposure to Sanofi SA, Coloplast AS and Alcon Inc. was negative for performance.
Currency effects had the most positive impact on the Fund’s performance. Stock selection in health care and consumer staples had a negative impact on performance.
Portfolio activity
0
Outlook
The sub-advisor favours attractively valued EAFE companies whose performance is not driven by macroeconomic events.